By Maryam Asim | Management Representative
Every blood transfusion gives a child with thalassaemia another chance at life. However, repeated transfusions also cause iron to gradually accumulate in the body, creating a serious health challenge known as iron overload.
Kashif Iqbal Thalassaemia Care Centre (Trust) aims to support children living with transfusion-dependent thalassaemia by ensuring continuous access to essential iron chelation therapy.
Iron chelation medicines help remove excess iron from the body and protect vital organs from long-term complications. Without consistent chelation therapy, accumulated iron can damage the heart, liver, and other organs, affecting patients' health and future quality of life.
Through this project, KITCC will provide essential iron chelation medicines, treatment monitoring, and medical support to children who depend on lifelong care.
Your support will ensure that these children receive not only the blood they need to survive, but also the protection they need to live healthier lives.
The Challenge
For children with severe thalassaemia, regular blood transfusions are necessary to maintain healthy haemoglobin levels.
However, every transfusion adds iron to the body. Since the human body cannot naturally remove excess iron efficiently, it gradually builds up over time.
This hidden accumulation can silently affect major organs. Without proper management, iron overload can lead to serious complications including heart problems, liver damage, and hormonal disorders.
Iron chelation therapy is therefore not an optional medicine, it is a vital part of long-term thalassaemia care.
Unfortunately, many families struggle to afford these medicines because patients require treatment for years, sometimes throughout their lifetime.
Our Solution
Through Every Dose Matters, KITCC will:
Who We Help
This project will support registered thalassaemia patients receiving treatment at Kashif Iqbal Thalassaemia Care Centre (Trust).
Many families visiting KITCC come from economically vulnerable backgrounds and cannot independently manage the lifelong cost of iron chelation medicines.
For these children, consistent access to medication can determine whether they continue growing safely or face preventable health complications.
Expected Impact
With donor support, this project will help:
Every dose represents protection.
Every month of treatment represents hope.
Why Your Support Matters
Your donation can help ensure that children do not have to choose between receiving essential medicines and meeting their daily needs.
Together, we can help children with thalassaemia live beyond treatment and move towards healthier futures.
Sustainability
KITCC continues to provide comprehensive thalassaemia care through donor partnerships, community support, and awareness initiatives.
By strengthening access to iron chelation therapy, this project contributes to a sustainable healthcare model where patients receive continuous support throughout their lifelong treatment journey.
Final Message
With your support, we can help children with thalassaemia receive the treatment they need, not just to survive, but to thrive.
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser